StrokeNCT03458884
Does Cardiorespiratory Interval Training Improve Post-stroke Fatigue
A study testing Cardiorespiratory interval training in people with Stroke and Fatigue, run by Umeå University at 1 site in Sweden.
Trial summary
Post-stroke fatigue is common and negatively influences post-stroke recovery. Today, there is insufficient evidence how to treatment post-stroke fatigue. Our objective is to investigate if a structured cardiorespiratory interval training program added to the early supported discharge (ESD)-service results in relieved… Read more about this study
- Who is it for?
- Ages 18 to 100 years
- What is being tested?
- Cardiorespiratory interval training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteSweden
- Study dates
- 19 Mar 2018to 1 Mar 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Preliminary or final diagnosis of acute stroke due to Brain infarction: large vessel disease, lacunar syndrome, cryptogenic stroke Intracerebral hemorrhage
- Post-stroke fatigue (defined as a summation score of 28 or more on the S-FAS)
- Medical stability
- Independent living in Umeå or Gävle (in the nearby surrounding areas) and able to cycle an ergometer cycle.
Who cannot join
- Patients with severe stroke with modified Rankin Scale >3
- Atrial fibrillation, pacemaker or other arrhythmia which exclude reliable monitoring of heart-frequency
- Unstable pulmonary or cardiac disease
- Serious co-morbidity with for example terminal cancer, hemodialysis, severe cognitive dysfunction with Montreal Cognitive Assessment (MOCA) ≤ 26
- Drug abuse
- Patients living far away from the hospital or in residential care facilities.
Trial locations and contacts
1 site in 1 country.
Sweden1 site, 1 recruiting
- Recruiting
Anna Bråndal
Umeå, s-90185
Anna Brandal, PhD, +702197609, anna.brandal@umu.se
About this study
Official title: Does a Cardiorespiratory Interval Training Program at Home Improve Post-stroke Fatigue?
Post-stroke fatigue is common and negatively influences post-stroke recovery. Today, there is insufficient evidence how to treatment post-stroke fatigue. Our objective is to investigate if a structured cardiorespiratory interval training program added to the early supported discharge (ESD)-service results in relieved post-stroke fatigue and increased oxygen uptake.
This is a 1:1 prospective randomized open- label trial(Two-centre study) with blinded evaluators (PROBE-design) of 50 participants referred to ESD with study start at 4 (±1) weeks after discharge from the stroke unit. The intervention group (N=25) receives a structured cardiorespiratory interval training program on ergometer cycle, 30-40 minutes, 3 days a week for 8 weeks. The cardiorespiratory interval training program comprises of 4x4 minute interval, at 70 to 80% of peak heart rate, interrupted by 3 minutes active recovery.
The control group (N=25) receives usual ESD care. The primary outcome will be a shift in the Swedish Fatigue Assessment Scale before intervention (baseline) versus 8 weeks months after start of intervention in the intervention and control groups. Secondary outcomes include cardiorespiratory fitness, compliance, adherence and adverse events.
Read the detailed description
Stroke is a major cause of disability among adults. After stroke, post-stroke fatigue is a common and negatively influences post-stroke recovery. Today, there is insufficient evidence how to treatment post-stroke fatigue. Post-stroke fatigue is considered to have a multifactorial cause and it is biologically plausible that fatigue might be related to physical deconditioning and reduced physical activity.
After stroke, functional limitations often lead to a reduction in physical activity, which in turn may lead to decline in cardiorespiratory fitness. Cardiorespiratory fitness is often measured as peak oxygen consumption, VO2peak. Studies have reported that physical activity and cardiorespiratory fitness is lower in stroke victims than gender- and aged-matched healthy individuals.
Intervention aimed to increased cardiorespiratory fitness has been highlighted as an important component in in stroke rehabilitation. Guidelines for physical activity and cardiorespiratory fitness following stroke recommend cardiorespiratory training 20-60 minutes, 3-7 days a week at 50-80% of maximal heart rate. Interval training (4 x 4 minutes) has showed to improve cardiovascular fitness at different patient groups, including Stroke.
Today, stroke unit and early supported discharge service (ESD) is recommended as an effective way to improve patient outcome and quality of care following stroke. The ESD service provides support and rehabilitation for the patients in their own environment and the rehabilitation is often focused on activities in daily living and mobility.
The objective of this study is to investigate if a structured cardiorespiratory interval training program added to the early supported discharge (ESD)-service results in relieved post-stroke fatigue and increased oxygen uptake. Furthermore, the study will explore whether it is feasible and safe for patients with post-stroke fatigue to perform a structured cardiorespiratory interval training program in their home environment.
Method/design
This is a 1:1 prospective randomized open-label trial (Two-centre study) with blinded evaluators (PROBE-design) comparing 8 weeks structured cardiorespiratory interval training program added to standard ESD care compared with standard ESD care alone in 50 patients with post-stroke fatigue.
Study participants
Consecutive stroke patients who receives stroke unit care followed by ESD-service at Umeå Stroke Center, University Hospital, Umeå, Sweden and Gävle hospital, Region Gävleborg, Sweden. A stroke physician will examine the patients 4 (± 1) weeks after discharge from the stroke unit. The patients fulfilling the eligibility criteria will receive oral and written information. Thereafter, the potential participants will be given at least 24 hours until they are asked for written informed consent.
After informed consent, an incremental cardiopulmonary exercise test will be performed on an ergometer cycle (pre-treatment test). The participants will also estimate post-stroke fatigue with the Swedish fatigue assessment scale (S-FAS).
Randomization
Participants (N=50) eligible for study participation according to inclusion and exclusion criteria will be randomly assigned to the intervention group(N=25) or the control group(N=25). The randomization procedure will be web-based using program Minim. Minimization will be used to create groups for intervention and control in order to stratify groups and ensure balance at study entry with respect to significant variables. The participants will be stratified according to sex, age and stroke severity (Modified Rankin Scale 0-1 vs ≥2).
Treatment
Stroke patients in the control group will receive usual ESD care including information about post-stroke fatigue, support and practical advice about how to identify and manage fatigue symptoms in daily tasks, such as the adaptation and prioritization of activities, physical activity and rest.
The participants in the intervention group will receive structured cardiorespiratory interval training program on an ergometer cycle. This is in addition to usual ESD care. The training will be conducted 30-40 minutes, 3 days a week for 8 weeks. Based on the incremental cardiopulmonary exercise test (pre-treatment test) an individual training heart rate range of 70 to 80% of maximal heart rate (HR peak) will be set. The participants will wear a heart rate monitor during the training and be instructed to exercise within the heart rate range. An experienced physiotherapist will be present and guide the training sessions during the first weeks. When the participants become more familiar with the exercise, the physiotherapist will monitor the training through phone or telemedicine equipment.
. The training session will start with a 10 minutes warm-up followed by 25 minutes of 4x4 minute interval, at 70 to 80% of peak heart rate, interrupted by 3 minutes active recovery and 5 minutes cool down. In order to get a estimation of perceived exertion, the participant will rate on The Borg Rating of Perceived Exertion (RPE) scale every minute during the 4-minute intervals.
Statistical analysis
The sample size was estimated by a power calculation. The power calculation was based on the level of fatigue assessed with the Swedish Fatigue Assessment scale (primary outcome). The absolute reliability for the Swedish Fatigue Assessment scale is 9 points, which means that a 9 points change is required to indicate a real change of fatigue level. 21 persons per group are needed for power of 80 % significance level of 0.05 (2 sided t-test, assuming a standard deviation of 10). This calculation is based on a t-test assuming a standard deviation of 10 points. A total of 50 participants (25 participants per group) will enter this study. The analyses of primary and secondary outcome will be on the basis of intension to treat. Two-sided students t-test or two-sided Wilcoxon signed rank test will be used to compare groups for the pre-treatment test and post treatment test.
- Being tested
- Cardiorespiratory interval training
- Keywords
- Stroke, Fatigue, PROBE design, Cardiorespiratory fitness, Cardiorespiratory training
- Medical subject headings
- Stroke, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cardiorespiratory interval trainingOther
A structured cardiorespiratory interval training program on an ergometer cycle 3 days a week for 8 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Cardiorespiratory interval training | Experimental | Cardiorespiratory interval training program on ergometer cycle, 30-40 minutes, 3 days a week for 8 weeks. Receives: Other: Cardiorespiratory interval training |
| Usual care | No intervention | Usual ESD care including information about post-stroke fatigue, support and practical advice about how to identify and manage fatigue symptoms in daily tasks, such as the adaptation and prioritization of activities, physical activity and rest. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Post-stroke fatigue
Post-stroke fatigue will be measured with The Swedish Fatigue Assessment Scale (S-FAS) comprises 10 questions that describe how a person generally feels. The answers are given using a 5-point scale ranging from 1 (never) to 5 (always) such that the total score ranges from 10 to 50 points. Items 4 and 10 require reversed scoring. A high score indicate an increase level of fatigue.
Measured: The S-FAS will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)
Secondary outcomes (4)
Cardiorespiratory fitness (Peak oxygen consumption, VO2peak)
Cardiorespiratory fitness will be determined by measuring peak oxygen consumption (VO2peak) in an incremental cardiopulmonary exercise test on a ergometer cycle
Measured: Cardiorespiratory fitness (peak oxygen consumption) will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)
Feasibility (Fidelity)
Fidelity will be measured by recording the number of sessions completed.
Measured: Fidelity will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks
Feasibility (Adherence)
Adherence will be measured by monitoring heart rate (HR) during the exercise
Measured: Adherence will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks
Feasibility (Adverse events)
Adverse events will be recorded by asking the participants to fill in a home-exercise logbook at each training session and reviewing hospital record.
Measured: Adverse events will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2018
- Study start19 Mar 2018
- Primary completion1 Dec 2024 (estimated)
- Study completion1 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- 1:1 prospective randomized open-label trial with blinded evaluators (PROBE-design)
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Umeå University
- Sponsor type
- University, hospital or other
- Collaborators
- Region Västerbotten
- Responsible party
- Principal investigator, Anna Brandal, Umeå University
- Investigators
- Anna Bråndal, PhD, Principal investigator, Department of Community Medicine and Rehabilitation, Physotherapy
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03458884
- Sponsor's protocol ID
- 2015-420-31M
- Status last verified
- May 2024
- First submitted
- 2 Mar 2018
- Last updated
- 13 May 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Brandal A, Svedjebrant M, Nilsagard Y, Wester P. Home-Based Supervised Cardiorespiratory Interval Training Decreases Poststroke Fatigue and Improves Cardiorespiratory Fitness: A Randomized Controlled Trial. Stroke. 2026 Jul;57(7):1941-1949. doi: 10.1161/STROKEAHA.125.054501. Epub 2026 May 6.
PubMed 42089147
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does a Cardiorespiratory Interval Training Program at Home Improve Post-stroke Fatigue?
- ClinicalTrials.gov ID
- NCT03458884
- Acronym / sponsor ID
- 2015-420-31M
- Keywords
- Stroke, Fatigue, PROBE design, Cardiorespiratory fitness, Cardiorespiratory training
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Umeå UniversityUniversity, hospital or other
- Collaborators
- Region Västerbotten
- Study start
- 19 Mar 2018 (actual)
- Primary completion
- 1 Dec 2024 (estimated)
- Study completion
- 1 Mar 2025 (estimated)
- First posted
- 8 Mar 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Post-stroke fatigue is common and negatively influences post-stroke recovery. Today, there is insufficient evidence how to treatment post-stroke fatigue. Our objective is to investigate if a structured cardiorespiratory interval training program added to the early supported discharge (ESD)-service results in relieved post-stroke fatigue and increased oxygen uptake.
This is a 1:1 prospective randomized open- label trial(Two-centre study) with blinded evaluators (PROBE-design) of 50 participants referred to ESD with study start at 4 (±1) weeks after discharge from the stroke unit. The intervention group (N=25) receives a structured cardiorespiratory interval training program on ergometer cycle, 30-40 minutes, 3 days a week for 8 weeks. The cardiorespiratory interval training program comprises of 4x4 minute interval, at 70 to 80% of peak heart rate, interrupted by 3 minutes active recovery.
The control group (N=25) receives usual ESD care. The primary outcome will be a shift in the Swedish Fatigue Assessment Scale before intervention (baseline) versus 8 weeks months after start of intervention in the intervention and control groups. Secondary outcomes include cardiorespiratory fitness, compliance, adherence and adverse events.
Detailed description
Stroke is a major cause of disability among adults. After stroke, post-stroke fatigue is a common and negatively influences post-stroke recovery. Today, there is insufficient evidence how to treatment post-stroke fatigue. Post-stroke fatigue is considered to have a multifactorial cause and it is biologically plausible that fatigue might be related to physical deconditioning and reduced physical activity.
After stroke, functional limitations often lead to a reduction in physical activity, which in turn may lead to decline in cardiorespiratory fitness. Cardiorespiratory fitness is often measured as peak oxygen consumption, VO2peak. Studies have reported that physical activity and cardiorespiratory fitness is lower in stroke victims than gender- and aged-matched healthy individuals.
Intervention aimed to increased cardiorespiratory fitness has been highlighted as an important component in in stroke rehabilitation. Guidelines for physical activity and cardiorespiratory fitness following stroke recommend cardiorespiratory training 20-60 minutes, 3-7 days a week at 50-80% of maximal heart rate. Interval training (4 x 4 minutes) has showed to improve cardiovascular fitness at different patient groups, including Stroke.
Today, stroke unit and early supported discharge service (ESD) is recommended as an effective way to improve patient outcome and quality of care following stroke. The ESD service provides support and rehabilitation for the patients in their own environment and the rehabilitation is often focused on activities in daily living and mobility.
The objective of this study is to investigate if a structured cardiorespiratory interval training program added to the early supported discharge (ESD)-service results in relieved post-stroke fatigue and increased oxygen uptake. Furthermore, the study will explore whether it is feasible and safe for patients with post-stroke fatigue to perform a structured cardiorespiratory interval training program in their home environment.
Method/design
This is a 1:1 prospective randomized open-label trial (Two-centre study) with blinded evaluators (PROBE-design) comparing 8 weeks structured cardiorespiratory interval training program added to standard ESD care compared with standard ESD care alone in 50 patients with post-stroke fatigue.
Study participants
Consecutive stroke patients who receives stroke unit care followed by ESD-service at Umeå Stroke Center, University Hospital, Umeå, Sweden and Gävle hospital, Region Gävleborg, Sweden. A stroke physician will examine the patients 4 (± 1) weeks after discharge from the stroke unit. The patients fulfilling the eligibility criteria will receive oral and written information. Thereafter, the potential participants will be given at least 24 hours until they are asked for written informed consent.
After informed consent, an incremental cardiopulmonary exercise test will be performed on an ergometer cycle (pre-treatment test). The participants will also estimate post-stroke fatigue with the Swedish fatigue assessment scale (S-FAS).
Randomization
Participants (N=50) eligible for study participation according to inclusion and exclusion criteria will be randomly assigned to the intervention group(N=25) or the control group(N=25). The randomization procedure will be web-based using program Minim. Minimization will be used to create groups for intervention and control in order to stratify groups and ensure balance at study entry with respect to significant variables. The participants will be stratified according to sex, age and stroke severity (Modified Rankin Scale 0-1 vs ≥2).
Treatment
Stroke patients in the control group will receive usual ESD care including information about post-stroke fatigue, support and practical advice about how to identify and manage fatigue symptoms in daily tasks, such as the adaptation and prioritization of activities, physical activity and rest.
The participants in the intervention group will receive structured cardiorespiratory interval training program on an ergometer cycle. This is in addition to usual ESD care. The training will be conducted 30-40 minutes, 3 days a week for 8 weeks. Based on the incremental cardiopulmonary exercise test (pre-treatment test) an individual training heart rate range of 70 to 80% of maximal heart rate (HR peak) will be set. The participants will wear a heart rate monitor during the training and be instructed to exercise within the heart rate range. An experienced physiotherapist will be present and guide the training sessions during the first weeks. When the participants become more familiar with the exercise, the physiotherapist will monitor the training through phone or telemedicine equipment.
. The training session will start with a 10 minutes warm-up followed by 25 minutes of 4x4 minute interval, at 70 to 80% of peak heart rate, interrupted by 3 minutes active recovery and 5 minutes cool down. In order to get a estimation of perceived exertion, the participant will rate on The Borg Rating of Perceived Exertion (RPE) scale every minute during the 4-minute intervals.
Statistical analysis
The sample size was estimated by a power calculation. The power calculation was based on the level of fatigue assessed with the Swedish Fatigue Assessment scale (primary outcome). The absolute reliability for the Swedish Fatigue Assessment scale is 9 points, which means that a 9 points change is required to indicate a real change of fatigue level. 21 persons per group are needed for power of 80 % significance level of 0.05 (2 sided t-test, assuming a standard deviation of 10). This calculation is based on a t-test assuming a standard deviation of 10 points. A total of 50 participants (25 participants per group) will enter this study. The analyses of primary and secondary outcome will be on the basis of intension to treat. Two-sided students t-test or two-sided Wilcoxon signed rank test will be used to compare groups for the pre-treatment test and post treatment test.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- 1:1 prospective randomized open-label trial with blinded evaluators (PROBE-design)
| Arm | Type | Receives |
|---|---|---|
| Cardiorespiratory interval training | Experimental | Other: Cardiorespiratory interval trainingCardiorespiratory interval training program on ergometer cycle, 30-40 minutes, 3 days a week for 8 weeks. |
| Usual care | No intervention | –Usual ESD care including information about post-stroke fatigue, support and practical advice about how to identify and manage fatigue symptoms in daily tasks, such as the adaptation and prioritization of activities, physical activity and rest. |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Preliminary or final diagnosis of acute stroke due to Brain infarction: large vessel disease, lacunar syndrome, cryptogenic stroke Intracerebral hemorrhage
- Post-stroke fatigue (defined as a summation score of 28 or more on the S-FAS)
- Medical stability
- Independent living in Umeå or Gävle (in the nearby surrounding areas) and able to cycle an ergometer cycle.
Key exclusion criteria (6 listed)
- Patients with severe stroke with modified Rankin Scale >3
- Atrial fibrillation, pacemaker or other arrhythmia which exclude reliable monitoring of heart-frequency
- Unstable pulmonary or cardiac disease
- Serious co-morbidity with for example terminal cancer, hemodialysis, severe cognitive dysfunction with Montreal Cognitive Assessment (MOCA) ≤ 26
- Drug abuse
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cardiorespiratory interval trainingA structured cardiorespiratory interval training program on an ergometer cycle 3 days a week for 8 weeks. | Other | Cardiorespiratory interval training |
Primary outcome
Post-stroke fatigue
Time frame: The S-FAS will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)
Post-stroke fatigue will be measured with The Swedish Fatigue Assessment Scale (S-FAS) comprises 10 questions that describe how a person generally feels. The answers are given using a 5-point scale ranging from 1 (never) to 5 (always) such that the total score ranges from 10 to 50 points. Items 4 and 10 require reversed scoring. A high score indicate an increase level of fatigue.
4 secondary outcomes
Cardiorespiratory fitness (Peak oxygen consumption, VO2peak)
Time frame: Cardiorespiratory fitness (peak oxygen consumption) will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)
Feasibility (Fidelity)
Time frame: Fidelity will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks
Feasibility (Adherence)
Time frame: Adherence will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks
Feasibility (Adverse events)
Time frame: Adverse events will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2024.
- Derived from this study: PubMed 42089147Brandal A, Svedjebrant M, Nilsagard Y, Wester P. Home-Based Supervised Cardiorespiratory Interval Training Decreases Poststroke Fatigue and Improves Cardiorespiratory Fitness: A Randomized Controlled Trial. Stroke. 2026 Jul;57(7):1941-1949. doi: 10.1161/STROKEAHA.125.054501. Epub 2026 May 6.
- Individual participant dataSharing planned: No
Related trials for Stroke
RecruitingPhase 1/2
Safety and Efficacy of CG-BM1 in Ischemic Stroke
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
Not yet recruitingPhase 3
Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence
Acute Ischemic Stroke
Recruiting
Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke
Stroke
Recruiting
Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy
Acute Ischemic Stroke
Not yet recruitingObservational study
The GEIR Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain
Retinal Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anna Bråndal, PhD principal investigator
Department of Community Medicine and Rehabilitation, Physotherapy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cardiorespiratory interval training in people with Stroke and Fatigue, run by Umeå University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Anna Bråndal, PhD (+46702197609, anna.brandal@umu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Post-stroke fatigue (time frame: The S-FAS will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03458884, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2024.